Welcome to our dedicated page for Innovage Holding news (Ticker: INNV), a resource for investors and traders seeking the latest updates and insights on Innovage Holding stock.
InnovAge Holding Corp. (Nasdaq: INNV) is a healthcare company that manages the care of high-cost, frail, and predominantly dual-eligible seniors through the Program of All-inclusive Care for the Elderly (PACE). The InnovAge news feed on Stock Titan highlights company announcements that reflect its role in senior care and its position as a market leader in PACE based on participants served.
News about InnovAge frequently covers financial results, including quarterly and annual earnings releases, updates on census (participants served), and guidance ranges for total revenues and Adjusted EBITDA. These items are often accompanied by Form 8-K filings and investor conference calls, giving context on how the business is performing and how management views its progress.
Investors and observers can also follow corporate developments such as leadership appointments in clinical and administrative roles, joint ventures, and strategic collaborations. For example, InnovAge has announced a joint venture involving its Florida PACE center in Tampa with Tampa General Hospital, aimed at expanding community-based care options for seniors. Other updates include participation in major healthcare conferences and recognition such as recertification as a Great Place to Work®.
The news stream additionally features mission- and advocacy-related activities, such as InnovAge’s sponsorship of a PBS documentary on caregiving, which aligns with its focus on supporting seniors and caregivers. Together, these updates provide a view into how InnovAge operates its PACE model, interacts with government payors and community partners, and communicates with shareholders. Bookmarking this page allows readers to monitor new earnings releases, governance updates, and strategic announcements related to INNV.
InnovAge Holding Corp. (Nasdaq: INNV) reported a fiscal Q1 2023 revenue of $171.2 million, down 1.1% from $173.1 million in Q1 2022. The net loss increased to $13.7 million from a net income of $7.6 million year-over-year, resulting in a loss per share of $(0.10). The company's Center-level Contribution Margin dropped 49.4% to $21.4 million. Adjusted EBITDA was negative $3.8 million, a steep decrease of $22 million compared to the previous year. As of September 30, 2022, InnovAge had $188.2 million in cash and $84.8 million in debt.
InnovAge Holding Corp. (Nasdaq: INNV) will announce its fiscal Q1 2023 financial results on November 8, 2022, post-market close. Following this, a conference call will be held at 5 p.m. E.T. to discuss the results. Interested parties can access a live audio webcast via InnovAge's website, and a replay will also be available post-call. InnovAge specializes in managing care for high-cost, dual-eligible seniors, serving approximately 6,650 participants across 18 centers in five states as of June 30, 2022.
InnovAge Holding Corp. (Nasdaq: INNV) reported its fiscal fourth quarter and full year results for 2022, with total revenues of $698.6 million, marking a 9.5% increase from 2021. Despite the revenue growth, the company faced a net loss of $8 million, improving from a $44.7 million loss in 2021. Adjusted EBITDA was $34.3 million, down significantly from $85.3 million in the previous year. The census decreased from approximately 6,850 to 6,650 participants. The company ended the year with $184.4 million in cash and equivalents and $86.4 million in debt.
InnovAge Holding Corp. (Nasdaq: INNV) will release its fiscal 2022 fourth quarter financial results on September 13, 2022, after market close. A conference call to discuss the results will be held at 5 p.m. E.T. Participants can access a live audio webcast on the company's website, with a replay available shortly after. InnovAge focuses on managing care for high-cost, dual-eligible seniors, serving approximately 6,800 participants across 18 centers in five states as of March 31, 2022.
InnovAge has appointed Kathy Andreasen as Chief People Officer, effective August 29, 2022. With over 25 years of experience in HR across various sectors, she aims to enhance the company’s organizational culture and talent management. InnovAge, a leader in healthcare for frail seniors through the PACE program, currently serves around 6,800 participants in five states. The company is focused on value-based care, partnering with Medicare and Medicaid, to ensure seniors can live independently while improving care quality and reducing costs.
InnovAge Holding Corp. (Nasdaq: INNV) announced the appointment of Dr. Richard Feifer as its new Chief Medical Officer effective August 15, 2022. With extensive experience in healthcare, particularly in post-acute care and value-based payment models, Feifer aims to enhance InnovAge's clinical care delivery, focusing on medical, pharmacy, and behavioral health services. InnovAge specializes in providing comprehensive healthcare programs for frail, dual-eligible seniors, serving around 6,800 participants across 18 centers in five states as of March 31, 2022.
InnovAge (NASDAQ: INNV) announced the appointment of Jim Carlson as the non-executive Chairman of its Board of Directors, effective June 30, 2022. Carlson brings extensive experience in coordinated healthcare, particularly for frail seniors. His tenure as CEO of Amerigroup saw significant growth, with revenues quadrupling. InnovAge aims to provide patient-centered care for dual-eligible seniors, serving about 6,800 participants across 18 centers in five states as of March 31, 2022.
LogicMark, Inc. (LGMK) announced the appointment of Barbara Gutierrez to its Board of Directors, where she will lead the Audit Committee. With over 30 years of financial leadership experience, Gutierrez is currently the CFO of InnovAge Holding Corp. (INNV) and brings extensive expertise in capital transactions and strategic planning. CEO Chia-Lin Simmons highlighted her pivotal role in enhancing the company's B2B focus and the broader care economy. LogicMark aims to redefine its position with innovative technologies and substantial market opportunities.
InnovAge Holding Corp. (Nasdaq: INNV) reported its fiscal Q3 results for the period ending March 31, 2022, with revenues of $177.4 million, up 13.5% year-over-year. The company’s participant census increased by 2.1% to approximately 6,800. However, net loss improved to $3.2 million compared to $10.9 million a year earlier. Center-level contribution margin decreased by 32.3%, and adjusted EBITDA dropped to $1.9 million from $20.3 million in Q3 2021. Dr. Melissa Welch announced her departure as Chief Medical Officer, with Dr. Ann M. Wells stepping in temporarily.
InnovAge Holding Corp. (Nasdaq: INNV) will release its 2022 fiscal third quarter financial results on May 10, 2022, after market close. A conference call will follow at 5 p.m. E.T. to discuss the results, accessible via phone and an audio webcast. InnovAge, a leader in managing care for high-cost, dual-eligible seniors, serves around 7,050 participants across 18 centers in five states. The company emphasizes a patient-centered care model, aiming to enhance care quality while minimizing high-cost care utilization.
FAQ
What is the current stock price of Innovage Holding (INNV)?
What is the market cap of Innovage Holding (INNV)?
